COMMENTARY

The Dow climbed higher due to DD as the company is going to split in two. Biotech once again was hit hard as sellers continue to pound the group. At one point today at the lows the NASDAQ was down more than 1% on the session. By the close, the NASDAQ was able to climb...

After a dismal jobs report Friday the market was able to confirm a new uptrend and we continued the gains today. Volume did not jump like it did on Friday, but was decent for a Monday. Biotech stocks continued to get hammered as fears over drug prices and the upcoming...

The late day rally in stocks erased sizeable intraday losses. Even after the past 3 days of trading the market still has yet to eclipse the highs set on Monday of this week. A positive here is we have held Monday's low for now. On the downside Europe continues its...

What has been a bad month for stocks we were able to go out on a high note. NASDAQ volume barely eclipsed yesterday's volume while NYSE volume was up 6% day-over-day. Now the question will be whether or not this was a dead-cat bounce. We are quite oversold from a...

Another disappointing session for stocks. While the S&P 500 and Dow finished higher they were off their highs. Small caps and Nasdaq continued their weak action. At this point it is not worth trying to force anything in this market. Cash remains King. Yesterday...

A very damning day for the stock market as sellers continue to dominate. We have been quit clear our view of this market and we continue to see the weakness play out day after day. There are not many stocks looking good after today's session. This leads us to believe...

Another roller coaster session for stocks as an afternoon rally pushes stocks near a high of day close. Volume jumped day-over-day, but stocks were unable to close at session highs. Durable goods orders fell, but did not fall as much as expected. Good news? At the end...